About us
About us
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys^®technology.
Explore this section
Who we are
Our business model
Our strategy
Board of directors
What we do
What we do
Futura Medical is developing a portfolio of innovative products for two large markets, sexual health and pain.
Explore this section
Our product development pipeline
MED3000
MED3000
MED3000 Overview
MED3000 CLINICAL PROGRAMME
MED3000 Commercial potential
Products FAQs
Products FAQs
MED3000 FAQs
FM71
Investor centre
Investor centre
Futura has a proven track record in delivery and completion of Research & Development projects up to value inflection points at which they are suitable for commercialisation partners.
WEBCASTS
Explore this section
Share price chart
Corporate documentation
Videos and webcasts
Videos and webcasts
Videos
Webcasts
RNS
Alert service
Shareholder centre
Shareholder centre
Investor contacts and advisors
Shareholder information
Financial calendar
Investor FAQs
Analyst Research
Corporate Governance
AIM rule 26
Media
Media
This section contains the latest RNS, news and videos.
Explore this section
News
Event calendar
RNS
Videos
Alert service
Contact us

About us
What we do
Investor centre
Media
Contact us

Financial calendar

Financial calendar

Home
Investor centre
Shareholder centre
Financial calendar

2024

Notice of results for year ended 31 December 2023
10 April 2024

You may also be interested in

Corporate documentation

Share price chart

©2024 Futura Medical

Sitemap
Contact us
Accessibility
Terms of use
Privacy & cookies policies

©2024 Futura Medical

Designed and developed by
jonesandpalmer.co.uk